QSS
COGT icon

Quantitative Systematic Strategies’s Cogent Biosciences COGT Stock Holding History

Quantitative Systematic Strategies’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-22,474
Closed -$182K – 85
2021
Q2 		$182K Sell
22,474
-25,287
-53% -$214K 0.06% 428
2021
Q1 		$419K Buy
47,761
+10,830
+29% +$104K 0.06% 403
2020
Q4 		$415K Buy
+36,931
New +$406K 0.06% 429
2019
Q1 		– Sell
-3,244
Closed -$57K – 446
2018
Q4 		$57K Buy
+3,244
New +$96K 0.01% 648

Other funds holding COGT

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Quantitative Systematic Strategies's COGT Position: Q3 2021 in Review

Quantitative Systematic Strategies sold out of Cogent Biosciences (COGT) in Q3 2021, closing a stake of 22,474 shares — an estimated $182K sold.

Quantitative Systematic Strategies first reported a position in COGT in Q4 2018 and held it in 4 quarters. The position peaked at $419K in Q1 2021. 73 funds tracked by Wall St. Rank hold COGT as of Q3 2021.

  • Quantitative Systematic Strategies reported no remaining Cogent Biosciences position as of Q3 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 22,474 Cogent Biosciences shares in Q3 2021, an estimated $182K.
  • Quantitative Systematic Strategies first reported a position in Cogent Biosciences in Q4 2018 and held it in 4 quarters.
  • Quantitative Systematic Strategies's Cogent Biosciences position peaked at $419K in Q1 2021.
  • 73 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q3 2021, filed 16 Nov 2021.